IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

China SXT Pharmaceuticals in (SXTC)

CUSIP: G2161P157 | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 14 institutional holders

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GOrca Capital AG1,112,7889.9%New 5%+ stakeOct 8, 2026No 13F filer matched
13GOrca Capital AG1,112,788
9.9% of class · Oct 8, 2026

Institutional Holders — Q4 2025

Citadel Advisors LLC150,576
0.0% of portfolio›$240.9K
Invesco Ltd.85,331
0.0% of portfolio›$136.5K
Geode Capital Management, LLC53,671
0.0% of portfolio›$85.9K
XTX Topco Ltd22,774
0.0% of portfolio›$36.4K
Virtu Financial LLC12,355
0.0% of portfolio›$20
Tower Research Capital LLC (TRC)1,827
0.0% of portfolio›$2.9K
Royal Bank of Canada818
0.0% of portfolio›$1.0K
UBS Group AG222
0.0% of portfolio›$356
StyleTurnoverLocationFiled
Citadel Advisors LLC
150,576$240.9K0.0%CoreVery HighMiami, FL2026-02-17
Invesco Ltd.
85,331$136.5K0.0%GrowthLowAtlanta, GA2026-07-15
Geode Capital Management, LLC
53,671$85.9K0.0%IndexVery LowBoston, MA2026-02-09
XTX Topco Ltd
22,774$36.4K0.0%ValueVery HighLondon, United Kingdom2026-02-17
Virtu Financial LLC
12,355$200.0%GARPVery HighNew York, NY2026-02-23
Tower Research Capital LLC (TRC)
1,827$2.9K0.0%GARPVery HighNew York, NY2026-02-17
Royal Bank of Canada
818$1.0K0.0%CoreLowToronto, Australia2026-02-17
UBS Group AG
222$3560.0%CoreMediumZurich, Switzerland2026-01-29
New 5%+ stake
No 13F filer matched